These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4458761)

  • 21. Elimination of pethidine and bupivacaine in the newborn.
    Cooper LV; Stephen GW; Aggett PJ
    Arch Dis Child; 1977 Aug; 52(8):638-41. PubMed ID: 921310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interferences with plasma assays in therapeutic drug monitoring.
    Yosselson-Superstine S
    Clin Pharmacokinet; 1984; 9(1):67-87. PubMed ID: 6362953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An HPLC method for the quantitation of quinidine and its metabolites in plasma: an application to a quinidine-phenytoin drug interaction study.
    Pershing LK; Peat MA; Finkle BS
    J Anal Toxicol; 1982; 6(3):153-6. PubMed ID: 7109560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma protein binding of phenytoin in 100 epileptic patients.
    Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
    Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bupivacaine binding to plasma protein fractions.
    Mather LE; Thomas J
    J Pharm Pharmacol; 1978 Oct; 30(10):653-4. PubMed ID: 30824
    [No Abstract]   [Full Text] [Related]  

  • 27. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
    Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
    Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis of phenytoin in a uremic patient.
    Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP
    Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(4):452-5. PubMed ID: 28926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pethidine binding in plasma: effects of methodological variables.
    La Rosa C; Mather LE; Morgan DJ
    Br J Clin Pharmacol; 1984 Apr; 17(4):411-5. PubMed ID: 6721987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS: Application in a pharmacokinetic study of a parturient with placental transfer.
    Souza MCO; Marques MP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2019 Feb; 164():268-275. PubMed ID: 30399533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of quinidine with anticonvulsant drugs.
    Data JL; Wilkinson GR; Nies AS
    N Engl J Med; 1976 Mar; 294(13):699-702. PubMed ID: 1250281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma protein binding and metabolic clearance of phenytoin in the rat.
    Colburn WA; Gibaldi M
    J Pharmacol Exp Ther; 1977 Dec; 203(3):500-6. PubMed ID: 925955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.